| Temporal relationship between sarcoidosis and malignancies in a nationwide cohort of 1942 patients |
|
| ADHERENCE TO THE MEDITERRANEAN DIET AND ITS ASSOCIATION WITH DISEASE ACTIVITY AND DAMAGE ACCRUAL IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
|
| Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study |
|
| Clinical and serological associations of autoantibodies in patients with systemic lupus erythematosus |
|
| Vitamin D Levels are Associated with Disease Activity and Damage Accrual in Systemic Lupus Erythematosus Patients |
|
| Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients |
|
| Clinical characterization and outcomes of 85 patients with neurosarcoidosis |
|
| Dietary Inflammatory Index Score and Cardiovascular Disease Risk Markers in Women with Systemic Lupus Erythematosus |
|
| Dietary Intake of Free Sugars is Associated with Disease Activity and Dyslipidemia in Systemic Lupus Erythematosus Patients |
|
| The Prognostic Nutritional Index and Nutritional Risk Index Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus |
|
| Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients |
|
| Differentiated Phenotypes at Diagnosis of Sarcoidosis According to the Scadding Classification: Analysis in 1230 Patients |
|
| THORACIC INVOLVEMENT AT DIAGNOSIS DRIVES A DIFFERENTIATED CLINICAL PRESENTATION OF SARCOIDOSIS: ANALYSIS OF 1245 PATIENTS (SARCOGEAS-SEMI) |
|
| Epidemiologic Subsets Drive a Differentiated Thoracic and Extrathoracic Presentation of Sarcoidosis: Analysis of 1082 Patients from the Sarcogeas-SEMI Registry |
|
| Immuno complex mediated acute glomerulonephritis in a patient with infectious mononucleosis |
|
| SARCOIDOSIS IN SPAIN: CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS AT DIAGNOSIS IN 1082 PATIENTS |
|
| Ethnicity-Related Differences in the Clinical Presentation of Sarcoidosis in Spain (SARCOGEAS-SEMI Registry) |
|
| How Does Sarcoidosis Present in Spain? Characteristics at Diagnosis of 979 Patients from the Sarcogeas-SEMI Registry |
|
| Sjogren syndrome and mixed nephropathy. Significance of early kidney biopsy |
|
| Sarcoidosis: an update on current pharmacotherapy options and future directions |
|
| Characteristics of patients with multiple disease hospitalized in Internal Medicine Services |
|
| The practice of Internal Medicine in Andalusia follows the evidence-based medicine basic principles |
|
| Appropriateness of use of gastroprotective agents in patients taking low-dose aspirin on a chronic basis |
|
| Are really objective the criteria of Appropriateness Evaluation Protocol (AEP)? |
|
| Hyperthyroidism secondary to kelp tablets ingestias |
|
| Letter to the editor [3] |
|
| Rehospitalization in internal medicine and short stays |
|
| Primary Sjogren's syndrome associated with autoimmune hepatitis |
|
| Predictive factors for inappropriate hospital stays in an internal medicine department |
|
| Megestrol-induced Cushing syndrome |
|
| Primary prevention of cardiovascular events by acetylsalicylic acid in patients with hypertension in Spain |
|
| Cauda equina syndrome and sacral lytic mass |
|
| Radiodiagnostics -: Postural syncope and dark gingival plaques |
|
| Síncope postural y placas oscuras gingivales |
|
| Síndrome de la cola de caballo y masa lítica sacra |
|
| Orlistat and articles accepted for publication in Medicina Clínica |
|
| What do the internal medicine residents of Anadalusia think of their specialty? Survey results |
|
| Pseudomyotony as presentation form of primary hypothyroidism |
|
| Pseudomyotonia as initial manifestation of primary hypothyroidism |
|
| Evidence-based medicine and antihypertensive treatments [1] |
|
| HEPATITIS-C VIRUS (HCV) ANTIBODIES IN HEMODIALYSIS-PATIENTS |
|
| HEPATITIS-C VIRUS (HCV) IN HEMODIALYSIS (HD) PATIENTS - CORRELATION BETWEEN CLINICAL, BIOCHEMICAL AND HISTOLOGICAL-FINDINGS |
|
| EVOLUTION OF LIPID PROFILES IN LONG-TERM PERITONEAL-DIALYSIS |
|
| CARPAL-TUNNEL SYNDROME (CTS) EFFECT ON HEMODIALYSIS AND CAPD - A COMPARATIVE-STUDY ON CHARACTERISTICS AND RISK-FACTORS |
|
| CIPROFLOXACIN - ROLE IN THE THERAPY OF CAPD CATHETER-RELATED SKIN INFECTIONS |
|
| GASTROINTESTINAL DIAGNOSTIC PROCEDURES IN CAPD PATIENTS - ITS USEFULNESS AND CLINICAL RENTABILITY |
|
| LONG-TERM FOLLOW-UP OF PERITONEAL FUNCTION DURING RHU-ERYTHROPOIETIN (EPO) TREATMENT IN CAPD PATIENTS |
|
| MEDIUM TERM RESPONSE TO H-R ERYTHROPOIETIN IN CAPD PATIENTS - THE INFLUENCE OF ERYTHROPOIETIN PLASMATIC LEVELS AND THE EFFECTS ON PERITONEAL TRANSPORT CAPACITY |
|
| CAPD IN THE ELDERLY - LONG-TERM FOLLOW-UP |
|
| CIPROFLOXACIN AS A TREATMENT FOR PERITONEAL CATHETER-RELATED SKIN INFECTIONS |
|
| CONTROL OF HYPERPARATYROIDISM IN CAPD PATIENTS WITH HIGH-DOSES OF 1,25(OH)D3 |
|
| ERYTHROPOIETIN EFFECT ON THE PHYSICAL CAPACITY OF HEMODIALIZED PATIENTS |
|
| EVALUATION OF ERYTHROCYTIC AGE-RELATED COMPOUNDS AFTER TREATMENT WITH ERYTHROPOIETIN OF HEMODIALYZED PATIENTS |
|
| MEASUREMENT OF PERITONEAL PLATELET ACTIVITY THROUGH EFFLUENT BETA-THROMBOGLOBULIN (BTG) LEVELS IN CAPD PATIENTS |
|
| SECONDARY HYPERPARATHYROIDISM IN CAPD PATIENTS - ITS SUPPRESSIBILITY WITH HIGH-DOSES OF CALCITRIOL |
|
| AMYLOID ARTHROPATHY IN DIALYZED PATIENTS - LONG-TERM FOLLOW-UP |
|
| ANTIBIOTIC-PROPHYLAXIS USED DURING PERITONEAL CATHETER PLACEMENT - A COMPARATIVE AND RANDOMIZED STUDY BETWEEN CEPHALOTINE AND VANCOMYCIN |
|
| CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS DOES NOT PREVENT THE DEVELOPMENT OF DIALYSIS-ASSOCIATED AMYLOIDOSIS |
|
| INDUCED CHANGES OF THE PERITONEAL DIFFUSION CAPACITY BY SMOKING, INTRAABDOMINAL HYPERTENSION AND OMENTECTOMY |
|
| PROGRESS IN THE PREVENTION OF EXOGENOUS CAPD PERITONITIS (ULTRAVIOLET CHAMBER AND DISCONNECTING SYSTEMS) |
|
| TICLOPIDINE EFFECTS ON PERITONEAL MICROCIRCULATION IN CAPD PATIENTS MEASURED THROUGH PERITONEAL MASS-TRANSFER |
|
